MCID: BRN049
MIFTS: 29

Brain Tumor, Childhood

Categories: Neuronal diseases, Rare diseases

Aliases & Classifications for Brain Tumor, Childhood

MalaCards integrated aliases for Brain Tumor, Childhood:

Name: Brain Tumor, Childhood 52
Childhood Brain Tumors 42
Childhood Brain Tumor 71

Classifications:



External Ids:

UMLS 71 C0220603

Summaries for Brain Tumor, Childhood

MedlinePlus : 42 Brain tumors are abnormal growths inside the skull. They are among the most common types of childhood cancers. Some are benign tumors, which aren't cancer. They can still be serious. Malignant tumors are cancerous. Childhood brain and spinal cord tumors can cause headaches and other symptoms. However, other conditions can also cause the same symptoms. Check with a doctor if your child has any of the following problems: Morning headache or headache that goes away after vomiting Frequent nausea and vomiting Vision, hearing, and speech problems Loss of balance or trouble walking Unusual sleepiness Personality changes Seizures Increased head size in infants The symptoms are not the same in every child. Doctors use physical and neurological exams, lab tests, and imaging to diagnose brain tumors. Most childhood brain tumors are diagnosed and removed in surgery. Treatment for children is sometimes different than for an adult. Long-term side effects are an important issue. The options also depend on the type of tumor and where it is. Removal of the tumor is often possible. If not, radiation, chemotherapy, or both may be used. NIH: National Cancer Institute

MalaCards based summary : Brain Tumor, Childhood, also known as childhood brain tumors, is related to childhood germ cell brain tumor and medulloblastoma, and has symptoms including seizures, tremor and back pain. The drugs Exenatide and Glucagon have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and spinal cord.

Related Diseases for Brain Tumor, Childhood

Diseases related to Brain Tumor, Childhood via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 97)
# Related Disease Score Top Affiliating Genes
1 childhood germ cell brain tumor 11.3
2 medulloblastoma 10.6
3 craniopharyngioma 10.2
4 hydrocephalus 10.2
5 hypothyroidism 10.1
6 brain cancer 10.1
7 germinoma 10.1
8 juvenile pilocytic astrocytoma 10.1
9 microcephaly, epilepsy, and diabetes syndrome 10.1
10 pineoblastoma 10.1
11 glioblastoma multiforme 10.0
12 teratoma 10.0
13 pituitary gland disease 10.0
14 protoplasmic astrocytoma 10.0
15 neurofibromatosis 10.0
16 glioma 10.0
17 hypogonadism 9.9
18 astrocytoma 9.9
19 malignant glioma 9.9
20 choroid plexus cancer 9.9
21 glial tumor 9.9
22 high-grade astrocytoma 9.9
23 li-fraumeni syndrome 9.9
24 3-methylglutaconic aciduria, type iii 9.9
25 body mass index quantitative trait locus 1 9.9
26 li-fraumeni syndrome 2 9.9
27 visual epilepsy 9.9
28 neutropenia 9.9
29 leukemia 9.9
30 squamous cell papilloma 9.9
31 papilledema 9.9
32 papilloma 9.9
33 lipid metabolism disorder 9.9
34 oligodendroglioma 9.9
35 neurilemmoma 9.9
36 childhood medulloblastoma 9.9
37 brain stem glioma 9.9
38 dysgerminoma 9.9
39 cerebellar astrocytoma 9.9
40 subependymal giant cell astrocytoma 9.9
41 fibrillary astrocytoma 9.9
42 childhood leukemia 9.9
43 germ cells tumors 9.9
44 hypothalamic obesity 9.9
45 low-grade astrocytoma 9.9
46 basal cell nevus syndrome 9.7
47 hypercholesterolemia, familial, 1 9.7
48 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.7
49 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.7
50 ocular motor apraxia 9.7

Graphical network of the top 20 diseases related to Brain Tumor, Childhood:



Diseases related to Brain Tumor, Childhood

Symptoms & Phenotypes for Brain Tumor, Childhood

UMLS symptoms related to Brain Tumor, Childhood:


seizures, tremor, back pain, headache, syncope, pain, chronic pain, sciatica, vertigo/dizziness, sleeplessness

Drugs & Therapeutics for Brain Tumor, Childhood

Drugs for Brain Tumor, Childhood (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 129)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Exenatide Approved, Investigational Phase 3 141758-74-9 15991534
2
Glucagon Approved Phase 3 16941-32-5
3
Histamine Approved, Investigational Phase 3 51-45-6 774
4
Cyproheptadine Approved Phase 3 129-03-3 2913
5 Hormone Antagonists Phase 3
6 Hormones Phase 3
7 Hypoglycemic Agents Phase 3
8 Anti-Obesity Agents Phase 3
9 Glucagon-Like Peptide 1 Phase 3
10 Incretins Phase 3
11 Dermatologic Agents Phase 3
12 Gastrointestinal Agents Phase 3
13 Neurotransmitter Agents Phase 3
14 Histamine Antagonists Phase 3
15 Anti-Allergic Agents Phase 3
16
Histamine Phosphate Phase 3 51-74-1 65513
17 Histamine H1 Antagonists Phase 3
18
Serotonin Investigational, Nutraceutical Phase 3 50-67-9 5202
19
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
20
Cisplatin Approved Phase 2 15663-27-1 2767 441203 84093
21
Sodium citrate Approved, Investigational Phase 2 68-04-2
22
Tamoxifen Approved Phase 2 10540-29-1 2733526
23
Phenylacetic acid Approved Phase 2 103-82-2 999
24
Sargramostim Approved, Investigational Phase 2 83869-56-1, 123774-72-1
25
Melphalan Approved Phase 2 148-82-3 460612 4053
26
Mechlorethamine Approved, Investigational Phase 2 51-75-2 4033
27
Iodine Approved, Investigational Phase 1, Phase 2 7553-56-2 807
28
Modafinil Approved, Investigational Phase 2 68693-11-8 4236
29
Megestrol acetate Approved, Investigational, Vet_approved Phase 2 595-33-5 11683
30
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
31
Lomustine Approved, Investigational Phase 2 13010-47-4 3950
32
Carboplatin Approved Phase 1, Phase 2 41575-94-4 10339178 38904 498142
33
Etoposide Approved Phase 1, Phase 2 33419-42-0 36462
34
Everolimus Approved Phase 2 159351-69-6 70789204 6442177
35
Dasatinib Approved, Investigational Phase 1, Phase 2 302962-49-8 3062316
36
Ifosfamide Approved Phase 1, Phase 2 3778-73-2 3690
37
Citric acid Approved, Nutraceutical, Vet_approved Phase 2 77-92-9 311
38 Molgramostim Investigational Phase 2 99283-10-0
39 interferons Phase 2
40 Poly ICLC Phase 2
41 Citrate Phase 2
42 Antineoplastic Agents, Hormonal Phase 2
43
Liposomal doxorubicin Phase 2 31703
44 Estrogen Receptor Modulators Phase 2
45 Estrogen Antagonists Phase 2
46 Estrogens Phase 2
47 Estrogen Receptor Antagonists Phase 2
48 Antibodies Phase 1, Phase 2
49 Antibodies, Monoclonal Phase 1, Phase 2
50 Immunoglobulins Phase 1, Phase 2

Interventional clinical trials:

(show top 50) (show all 57)
# Name Status NCT ID Phase Drugs
1 Music Video and Adolescent/Young Adult Resilience During Transplant Completed NCT00305851 Phase 3
2 Glucagon-Like Peptide-1 Agonist Effects on Energy Balance in Hypothalamic Obesity Active, not recruiting NCT02664441 Phase 3 Exenatide;placebo
3 Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
4 Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors Unknown status NCT00004659 Phase 2
5 Phase II Study of the Combination of Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents at Diagnosis or in Relapse Unknown status NCT00360945 Phase 2 cisplatin;temozolomide
6 A Phase II Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas Unknown status NCT01188096 Phase 2 Poly ICLC
7 Cisplatin, Doxorubicin and Tamoxifen in the Treatment of Incurable Soft Tissue and Endocrine Malignancies Completed NCT00002608 Phase 2 cisplatin;doxorubicin hydrochloride;tamoxifen citrate
8 Phase II Study of Phenylacetate in Pediatric Patients With Central Nervous System Tumors Completed NCT00003241 Phase 2 phenylacetate
9 Dose-Intensive Melphalan and Cyclophosphamide With Autologous Bone Marrow Rescue for Recurrent Medulloblastoma and Germ Cell Tumors Completed NCT00002594 Phase 2 cyclophosphamide;melphalan
10 Phase II Study of Antineoplastons A10 and AS2-1 in Children With Brain Tumors Completed NCT00003458 Phase 2 Antineoplaston therapy (Atengenal + Astugenal)
11 A Phase II Trial of Intravenous Cereport (RMP-7) and Carboplatin in Childhood Brain Tumors Completed NCT00019422 Phase 2 carboplatin;lobradimil
12 PHASE I STUDY OF ANTI-TENASCIN MONOCLONAL ANTIBODY 131I 81C6 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY IN THE TREATMENT OF PATIENTS WITH PRIMARY OR METASTATIC MALIGNANT BRAIN TUMORS Completed NCT00002752 Phase 1, Phase 2
13 A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor Completed NCT01381718 Phase 2 modafinil
14 A Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas and Recurrent or Progressive Brainstem Tumors Completed NCT00275002 Phase 2 O6-benzylguanine;temozolomide
15 The Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With Cancer/Treatment Related Cachexia Completed NCT00066248 Phase 2 cyproheptadine hydrochloride;megestrol acetate
16 Phase 2 Trial of Indoximod With Chemotherapy and Radiation for Children With Progressive Brain Tumors or Newly Diagnosed DIPG Recruiting NCT04049669 Phase 2 Indoximod;Indoximod;Temozolomide;Cyclophosphamide;Etoposide;Lomustine
17 Dasatinib With Ifosfamide, Carboplatin, Etoposide: A Pediatric Phase I/II Trial Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
18 Phase II Study of Everolimus (RAD001, Afinitor®) for Children With Recurrent or Progressive Ependymoma Active, not recruiting NCT02155920 Phase 2 Everolimus
19 Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Oligodendroglioma Terminated NCT00003472 Phase 2 Antineoplaston therapy (Atengenal + Astugenal)
20 Phase II Study of Antineoplastons A10 and AS2-1 in Children With Primary Malignant Brain Tumors Terminated NCT00003476 Phase 2 Antineoplaston therapy (Atengenal + Astugenal)
21 A Phase I/II Study Of A Recombinant Chimeric Protein Composed Of Transforming Growth Factor (TGF)-a And A Mutated Pseudomonas Exotoxin Termed PE38 (TP-38) In Pediatric Patients With Recurrent Or Progressive Supratentorial High Grade Gliomas Terminated NCT00074334 Phase 1, Phase 2
22 Phase I/II Trial Of Intracerebral IL13-PE38QQR Infusions In Pediatric Patients With Recurrent Malignant Glioma Withdrawn NCT00053040 Phase 1, Phase 2
23 Photodynamic Therapy For Childhood Brain Tumors, A Phase I Study Unknown status NCT00002647 Phase 1 verteporfin
24 Phase I Studies of TARCEVA™ (ERLOTINIB HYDROCHLORIDE, OSI-774) as Single Agent in Children With Refractory and Relapsed Malignant Brain Tumors and in Combination With Irradiation in Newly Diagnosed Brain Stem Glioma Unknown status NCT00360854 Phase 1 erlotinib hydrochloride
25 Phase I Study of Doxorubicin HCl Liposome in Pediatric Patients With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
26 A Phase I Trial and Pharmacokinetic Study of Talabostat (PT-100, Val-Boro-Pro) in Combination With Temozolomide or Carboplatin in Pediatric Patients With Relapsed or Refractory Solid Tumors Including Brain Tumors Completed NCT00303940 Phase 1 carboplatin;talabostat mesylate;temozolomide
27 TREATMENT OF CHILDREN AND YOUNG ADULTS WITH RECURRENT/REFRACTORY SOLID TUMORS WITH HIGH DOSE ETOPOSIDE AND CARBOPLATIN PLUS ESCALATING DOSE CYCLOPHOSPHAMIDE, FOLLOWED BY HEMATOPOIETIC RESCUE USING AUTOLOGOUS CD34+ SELECTED BLOOD STEM CELLS: A PILOT STUDY Completed NCT00007813 Phase 1 carboplatin;cyclophosphamide;etoposide
28 PROTOCOL FOR A PHASE I STUDY OF INTRACYSTIC ANTI-TENASCIN MONOCLONAL ANTIBODY 131I 81C6 IN THE TREATMENT OF PATIENTS WITH RECURRENT CYSTIC GLIOMAS Completed NCT00002753 Phase 1
29 GALLIUM NITRATE FOR THE TREATMENT OF MALIGNANT TUMORS, A PHASE I STUDY Completed NCT00002543 Phase 1 gallium nitrate
30 Phase I and Pharmacokinetic Trial of PTC299 in Pediatric Patients With Refractory or Recurrent CNS Tumors Completed NCT01158300 Phase 1 VEGF inhibitor PTC299
31 Phase I Study of Intrathecal Spartaject-Busulfan in Children With Neoplastic Meningitis Completed NCT00006246 Phase 1 busulfan
32 A Phase I Study Of Vaccination With Telomerase Peptide Plus GM-CSF Completed NCT00069940 Phase 1
33 A Phase I, Open Label, Maximum Tolerated Dose-Finding Study to Evaluate the Safety and Tolerability of 90Y-DOTA-tyr3-Octreotide Administered by Intravenous Infusion to Children With Refractory Somatostatin-Receptor Positive Tumors Completed NCT00049023 Phase 1
34 A Phase I Study of Valproic Acid in Children With Recurrent/Progressive Solid Tumors Including CNS Tumors Completed NCT00107458 Phase 1 valproic acid
35 A Phase I Study of Temozolomide, Oral Irinotecan, and Vincristine for Children With Refractory Solid Tumors Completed NCT00138216 Phase 1 irinotecan hydrochloride;temozolomide;vincristine sulfate
36 Phase I Trial and Pharmacokinetic Study of Temozolomide and O6-Benzylguanine in Childhood Solid Tumors Completed NCT00020150 Phase 1 O6-benzylguanine;temozolomide
37 Phase I and Pharmacokinetic Study of Enzastaurin (LY317615) in Children and Adolescents With Refractory Primary CNS Tumors Completed NCT00503724 Phase 1 enzastaurin hydrochloride
38 A Multi-center Phase I Trial of Temsirolimus in Combination With Valproic Acid in Children and Adolescents With Multiply Relapsed Pediatric Solid Tumors Terminated NCT01204450 Phase 1 Temsirolimus;Valproic Acid
39 Phase I Dose Escalation Study of N-Acetylcysteine Administered in Conjunction With Carboplatin, Cyclophosphamide, and Etoposide Phosphate BBBD, in Children With Malignant Brain Tumors Terminated NCT00238173 Phase 1 acetylcysteine;carboplatin;cyclophosphamide;etoposide phosphate;mannitol;sodium thiosulfate
40 A Phase I Study Of Talotrexin (PT-523) In Children And Adolescents With Recurrent Solid Tumors Or Recurrent/Refractory Leukemias Withdrawn NCT00458744 Phase 1 talotrexin
41 Complimentary Hyperbaric Oxygen for Brain Radionecrosis Unknown status NCT00087815 dexamethasone;hyperbaric oxygen
42 The Feasibility of Selecting Patient-Specific Biologically Targeted Therapy With Sorafenib, Everolimus, Erlotinib or Dasatinib for Pediatric Patients With Refractory Or Recurrent Brain Tumors Unknown status NCT02015728 Temozolomide;Etoposide;Sorafenib;Everolimus;Erlotinib;Dasatinib
43 Expression and Subcellular Localization of NEIL3 in Tumors Completed NCT01585389
44 Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples Completed NCT01650922
45 A Randomized Control Trial to Evaluate the Efficacy of a Group Social Skills Intervention for Childhood Survivors of Brain Tumours Completed NCT02677142
46 Analyses of Mutations Associated With Secondary Leukemia or Non-Hodgkin's Lymphoma in Patients Treated for Hodgkin's Disease or Childhood Brain Tumors Completed NCT00006342
47 Improving Well-being Among Young Adult Survivors of Childhood Brain Tumor: A Randomized Controlled Trial of a Brief Internet-based Behavioral Activation Program Completed NCT03871686
48 Effectiveness of Musical Training in Reducing Depressive Symptoms, Enhancing Self-esteem and Quality of Life Among Hong Kong Chinese Childhood Brain Tumor Survivors - A Pilot Randomized Controlled Trial Completed NCT03399864
49 Working Memory Performance Among Childhood Brain Tumor Survivors Treated With Conformal Radiation Therapy: A Pilot Study Completed NCT00693914
50 KEYS to Succeed: Cognitive and Academic Intervention Program for Children and Adolescents Surviving Cancer Completed NCT02573441

Search NIH Clinical Center for Brain Tumor, Childhood

Genetic Tests for Brain Tumor, Childhood

Anatomical Context for Brain Tumor, Childhood

MalaCards organs/tissues related to Brain Tumor, Childhood:

40
Brain, Testes, Spinal Cord, Bone, Bone Marrow, Liver, Pituitary

Publications for Brain Tumor, Childhood

Articles related to Brain Tumor, Childhood:

(show top 50) (show all 522)
# Title Authors PMID Year
1
Imaging of Neuronal and Mixed Glioneuronal Tumors. 42
32217897 2020
2
Development and validation of a nomogram to predict the overall survival of patients with neuroblastoma. 42
32150058 2020
3
Complications of stereotactic biopsy of lesions in the sellar region, pineal gland, and brainstem: A retrospective, single-center study. 42
32080071 2020
4
Exposure to lead increases the risk of meningioma and brain cancer: A meta-analysis. 61
32146339 2020
5
Identification of new therapeutic targets and natural compounds against diffuse intrinsic pontine glioma (DIPG). 61
32311581 2020
6
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource. 61
32519082 2020
7
Molecular-Targeted Therapy for Childhood Brain Tumors: A Moving Target. 61
32552173 2020
8
Considerations for Reliable Digit Span as a performance validity test for long-term survivors of childhood brain tumors. 61
32503366 2020
9
Systematic review: measurement properties of patient-reported outcome measures evaluated with childhood brain tumor survivors or other acquired brain injury. 61
32537177 2020
10
Symptom burden trajectories experienced by patients with brain tumors. 61
32374469 2020
11
Medulloblastoma, macrocephaly, and a pathogenic germline PTEN variant: Cause or coincidence? 61
32419380 2020
12
Double Dissociation of Auditory Attention Span and Visual Attention in Long-Term Survivors of Childhood Cerebellar Tumor: A Deterministic Tractography Study of the Cerebellar-Frontal and the Superior Longitudinal Fasciculus Pathways. 61
32342828 2020
13
Assessment of everyday executive functioning using the BRIEF in children and adolescents treated for brain tumor. 61
32050813 2020
14
Circulating leptin levels are associated with adiposity in survivors of childhood brain tumors. 61
32170116 2020
15
Generation of diffuse intrinsic pontine glioma mouse models by brainstem-targeted in utero electroporation. 61
31638150 2020
16
Behavioral outcome among survivors of childhood brain tumor: a case control study. 61
32020861 2020
17
Metabolic response to exercise in childhood brain tumor survivors: A pilot controlled study. 61
31625676 2020
18
Subgroup-specific outcomes of children with malignant childhood brain tumors treated with an irradiation-sparing protocol. 61
31375903 2020
19
Intracranial tumors in children: a 10-year review from a single tertiary health-care center. 61
31267185 2019
20
Stalled developmental programs at the root of pediatric brain tumors. 61
31768071 2019
21
Diagnostic accuracy and added value of qualitative radiological review of 1H-magnetic resonance spectroscopy in evaluation of childhood brain tumors. 61
31832213 2019
22
Challenges to Family Management for Caregivers of Adolescent and Young Adult Survivors of Childhood Brain Tumors [Formula: see text]. 61
31046569 2019
23
The association between birth order and childhood brain tumors: a systematic review and meta-analysis. 61
30399044 2019
24
High occurrence of sleep problems in survivors of a childhood brain tumor with neurocognitive complaints: The association with psychosocial and behavioral executive functioning. 61
31418996 2019
25
Risk factors for childhood and adult primary brain tumors. 61
31301133 2019
26
Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study. 61
31079182 2019
27
Worldwide Trends in Survival From Common Childhood Brain Tumors: A Systematic Review. 61
31682549 2019
28
Radiation-Induced Meningiomas After Childhood Brain Tumor: A Magnetic Resonance Imaging Screening Study. 61
31063432 2019
29
Family history of cancer and the risk of childhood brain tumors: a pooled analysis of the ESCALE and ESTELLE studies (SFCE). 61
31399828 2019
30
Lack of KBTBD4 Mutations in Molecularly Classified Brazilian Medulloblastomas. 61
31403685 2019
31
Childhood brain tumors in Mali. 61
31573520 2019
32
The Effects of Radiation and Sex Differences on Adaptive Functioning in Adult Survivors of Pediatric Posterior Fossa Brain Tumors. 61
31084659 2019
33
Pituitary disease in pediatric brain tumor survivors. 61
31131647 2019
34
Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors. 61
31200562 2019
35
Hypothalamic-pituitary function following childhood brain tumors: Analysis of prospective annual endocrine screening. 61
30693650 2019
36
Perinatal and early life risk factors for childhood brain tumors: Is instrument-assisted delivery associated with higher risk? 61
30818125 2019
37
Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome. 61
30478739 2019
38
Meaning Making and Religious Engagement Among Survivors of Childhood Brain Tumors and Their Caregivers. 61
30767968 2019
39
Neurological predictor scale is associated with academic achievement outcomes in long-term survivors of childhood brain tumors. 61
30607706 2019
40
Childhood brain tumors: current management, biological insights, and future directions. 61
30835699 2019
41
A Nationwide, Population-Based Epidemiologic Study of Childhood Brain Tumors in Korea, 2005-2014: A Comparison with United States Data. 61
30348678 2019
42
Metabolic syndrome is a sequela of radiation exposure in hypothalamic obesity among survivors of childhood brain tumors. 61
30530528 2019
43
Guidelines for Treatment and Monitoring of Adult Survivors of Pediatric Brain Tumors. 61
30739214 2019
44
Health status, Health-Related Quality of Life and Socio-economic Outcome in Childhood Brain Tumor Survivors: a German Cohort Study. 61
30793186 2019
45
Neurodevelopmental model of long-term outcomes of adult survivors of childhood brain tumors. 61
28956496 2019
46
A Congenital Case of Ependymoblastoma: A Rare and Aggressive Brain Tumor. 61
29432310 2019
47
Infratentorial immature teratoma of congenital origin can be associated with a 20-year survival outcome: a case report and review of literature. 61
30660187 2019
48
Neuroimaging of the component white matter connections and structures within the cerebellar-frontal pathway in posterior fossa tumor survivors. 61
31229941 2019
49
Combined functional genomic and chemical screens identify SETD8 as a therapeutic target in MYC-driven medulloblastoma. 61
30626740 2019
50
Delays in diagnosis for children with newly diagnosed central nervous system tumors. 61
31386013 2018

Variations for Brain Tumor, Childhood

Expression for Brain Tumor, Childhood

Search GEO for disease gene expression data for Brain Tumor, Childhood.

Pathways for Brain Tumor, Childhood

GO Terms for Brain Tumor, Childhood

Sources for Brain Tumor, Childhood

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....